Balakrishnan Sindhu, Kumar Lakshmi, Daniel Divya, Surendran Sudhindran
Department of Anaesthesiology and Critical Care, Amrita Institute of Medical Sciences, Amrita Vidya Vishwapeetham, Kochi, Kerala, India.
Department of Gastrosurgery and Solid Organ Transplant, Amrita Institute of Medical Sciences, Amrita Vidya Vishwapeetham, Kochi, Kerala, India.
Indian J Anaesth. 2021 Apr;65(4):331-335. doi: 10.4103/ija.IJA_1295_20. Epub 2021 Apr 15.
ABO incompatible liver transplants (ABOi LT) are considered as a life-saving option when compatible donor grafts are unavailable. Fourteen adults (right lobe graft) and three children (left lateral segment/lobe) who underwent ABOi LT from living donors between 2011 and 20 period were analysed for transfusions and desensitisation protocols. All recipients received packed red blood cells (PRBC) of their own group. AB plasma that does not contain any antibody was transfused in eight patients and donor group plasma in others. None of the patients developed transfusion related complications. Plasmapheresis and rituximab/bortezumab desensitisation was practised in 11 patients, only rituximab in four, only plasmapheresis in one, and no treatment in a 1 year child. Rejection was manifest in three patients while nine patients developed infections and sepsis. A working knowledge of the blood and product transfusions in ABOi LT is crucial for the anaesthesiologist. Perioperative management and impact of desensitisation protocol are discussed.
当无法获得相容的供体移植物时,ABO血型不相容肝移植(ABOi LT)被视为一种挽救生命的选择。对2011年至20期间接受活体供体ABOi LT的14名成年人(右叶移植物)和3名儿童(左外侧段/叶)进行了输血和脱敏方案分析。所有受者均接受了自身血型的浓缩红细胞(PRBC)。8例患者输注了不含任何抗体的AB型血浆,其他患者输注了供体血型血浆。所有患者均未发生输血相关并发症。11例患者采用了血浆置换和利妥昔单抗/硼替佐米脱敏治疗,4例仅采用利妥昔单抗治疗,1例仅采用血浆置换治疗,1名1岁儿童未接受任何治疗。3例患者出现排斥反应,9例患者发生感染和脓毒症。对于麻醉医生而言,掌握ABOi LT中的血液和血液制品输血知识至关重要。本文讨论了围手术期管理和脱敏方案的影响。